Table 2 Patient demographic and clinical characteristics at baseline according to gender (Phase 2)
Mean ± SD | Women (103) | Men (71) | Overall (174) |
|---|---|---|---|
Age (years) | 81. ± 7.5 | 80.5 ± 7.0 | 80.8 ± 7.3 |
Weight (kg) | 61.9 ± 10.7 | 73.9 ± 10.1 | 66.8 ± 12.0 |
Height (m) | 1.5 ± 0.1 | 1.7 ± 0.1 | 1.6 ± 0.1 |
BMI (Kg/m2) | 26.0 ± 4.2 | 26.6 ± 3.1 | 26.3 ± 3.8 |
SBP (mm Hg) | 136.3 ± 1932 | 132.4 ± 17.8 | 134.7 ± 18.7 |
DBP (mm Hg) | 75.8 ± 12.0 | 73.9 ± 12.6 | 75.0 ± 12.6 |
Creatinine (mg/dl) | 1.0 ± 0.3 | 1.5 ± 1.1 | 1.2 ± 0.8 |
Body surface (m2) | 1.6 ± 0.2 | 1.8 ± 0.2 | 1.7 ± 0.2 |
GFR (ml/min/1.73 m2) | 61.3 ± 14.5 | 59.8 ± 20.0 | 60.7 ± 17.0 |
CrCl (ml/min) | 45.2 ± 11.2 | 46.9 ± 15.2 | 45.9 ± 12.3 |
CrCl-BS (ml/min/1.73 m2) | 48.3 ± 11.5 | 45.2 ± 13.9 | 47.1 ± 12.6 |
Total number of drugs per patient | 6.3 ± 3.3 | 6.2 ± 3.0 | 6.3 ± 3.1 |
Drugs wit restriction in RI per patient | 3.5 ± 2.1 | 3.5 ± 2.0 | 3.5 ± 2.1 |
Number of DRP per patient | 0.4 ± 0.9 | 0.6 ± 1.0 | 0.5 ± 0.9 |
Prevalence of DI (%) | 18.9 ± 30.7 | 12.4 ± 24.2 | 15.5 ± 28.6 |
Population with DRP %(n) | 35.0(36) | 19.7(14) | 28.7(50) |
Comorbidity %(n) | |||
Hypertension | 709.%(73) | 67.6%(48) | 69.5%(121) |
T2Dm | 13.6%(14) | 8.5%(6) | 11.5%(20) |
Dyslipidemia | 42.%(44) | 29.6%(21) | 37.4%(65) |
Hyper/Hypo/Thy | 9.7%(10) | 1.4%(1) | 6.3%(11) |
CVD | 19.4%(20) | 29.6%(21) | 23.6%(41) |